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PTXa b s t r a c t
Succinate has been reported as the endogenous ligand for GPR91. In this study, succinate was con-
ﬁrmed to activate GPR91 resulting in both 30–50-cyclic adenosine monophosphate (cAMP) inhibition
and inositol phosphate formation in a pertussis toxin (PTX)-sensitive manner. GPR91 agonist-med-
iated effects detected using dynamic mass redistribution (DMR) were inhibited with PTX, edelfosine
and U73122 demonstrating the importance of not only the Gai pathway but also PLCb. These results
show that GPR91 when expressed in HEK293s cells couples exclusively through the Gai pathway and
acts through Gai not only to inhibit cAMP production but also to increase intracellular Ca2+ in an
inositol phosphate dependent mechanism via PLCb activation.
 2013 The authors. Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction to four subfamilies that in turn activate a small number of effectorG-protein-coupled receptors (GPCRs) constitute the largest
family of cell-surface proteins and are activated by a diverse range
of extracellular stimuli or ligands including amino acids, peptides,
lipids, nucleotides and photons. As a result GPCRs play an essential
role in regulating many physiological functions including neuro-
transmission, metabolism, secretion and cell growth. GPCRs are
so named as stimulation by a ligand results in the receptor cou-
pling to a trimeric G-protein which in turn dissociates into its sub-
units Ga and Gbc that subsequently modulate downstream
effectors. There are at least 18 different subtypes of Ga belongingmolecules [1]. Studies on the function of members of the Gai/Gao
family have often been performed using a toxin from Clostridium
botulinum pertussis toxin (PTX) that inhibits activity of this family.
Whilst many other G-protein-dependent signalling processes are
resistant to PTX [2], some Gbc downstream signalling events
dependent on Gai activation are inhibited by PTX. GPCR-dependent
phospholipase C (PLC) activation is mediated by PTX-sensitive and
-insensitive mechanisms [3,4]. The PTX-insensitive pathways are
primarily mediated by Gaq-dependent activation of PLCb or path-
ways involving Rho and PLCe [4–6], whilst PTX-sensitive pathways
are mediated by members of the Gai family [7,8].
Succinate has been reported as an endogenous ligand for
GPR91, a class A GPCR [9]. Succinate is a well-known intermedi-
ate in the tricarboxylic acid (Krebs) cycle, where it is formed
from succinyl-CoA by succinyl-CoA synthetase and subsequently
converted by succinate dehydrogenase to generate fumarate. Be-
cause the succinate dehydrogenase complex is part of the elec-
tron transport chain in the mitochondrial membrane, its
activity indirectly depends on the availability of oxygen. As such,
in situations when oxygen tension is low, succinate accumulates
because of low activity of succinate dehydrogenase or other en-
zymes in the electron transport chain that affect its activity [10–
12]. Transport of succinate to the extracellular compartment is
likely to occur through porins and the succinate-fumarate/malate
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agonist for GPR91 [14,15]. GPR99 is the closest homologue, shar-
ing 33% protein sequence identity with GPR91. GPR99 has also
been ‘‘deorphanized’’ with another Krebs cycle intermediate, a-
ketoglutarate which appear to be its ligand of choice [9].
GPR91 is expressed in a range of different tissues such as kidney,
liver, adipose, spleen, heart, retina and intestine [9,16]. In the
kidney, succinate-induced activation of GPR91 is reported to reg-
ulate the renin-angiotensin system and suggested to be impor-
tant in the development of renovascular hypertension and
diabetic nephropathy [9,17]. Succinate effect on GPR91 in neuro-
nal retinal ganglion cells has been reported to have a pro-angio-
genic effect involved in retinopathy of prematurity [18]. In a
recombinant system expressing GPR91, succinate is claimed to
activate both Gai- and Gaq-mediated signalling pathways, inhib-
iting forskolin-stimulated 30–50-cyclic adenosine monophosphate
(cAMP) production and stimulating Ca2+-mobilization [9,19]. In
contrast to this succinate is reported to induce inositol phos-
phate accumulation exclusively through the Gai pathway in an
erythroleukemic cell line TF-1 [20]. HEK293s cells are routinely
used to recombinant express GPCRs and the resulting cell lines
are often used to identify synthetic ligands, however this can
be misguided if the signalling property of the system is altered.
The purpose of the present study therefore was threefold: (1) to
determine if GPR91 receptor activation in our recombinant
HEK293s cell line couples through the Gai, Gaq or both path-
ways; (2) to examine the PTX sensitivity of GPR91-mediated
cAMP and IP3 formation; (3) to examine the mechanism of
GPR91 agonist-mediated effects on IP3 formation.
2. Materials and methods
2.1. Cloning of hGPR91, cell culture and membrane preparation
Full length DNA for human succinate receptor 1 (SUCNR1)
(NM_033050) (GeneArt (Life Technologies)) was sub cloned into
a pIRESneo3 vector (Clontech) and HEK293s cells (ATCC) were
transfected using Lipofectamine™ 2000 (Life Technologies). A
single clone was selected using ﬂuorescence-activated cell sort-
ing (FACS) sorting and a Ca2+-mobilization assay. Cells were cul-
tured at 37 C, 5% CO2 and 95% humidity in DMEM
supplemented with 10% FBS and 800 lg/ml G418 (Invitrogen).
Membranes were prepared using standard methods. Protein con-
centrations were determined with BCA protein assay kit (Pierce
biotechnology).
2.2. Treatment with inhibitors
Cells were treated with 100 ng/ml PTX (Sigma) for 18–24 h be-
fore being used in cAMP, inositol-1-phosphate (IP1) or dynamic
mass redistribution (DMR) assays, or for membrane preparation
and guanosine 50-[c-35S]-triphosphate (GTPcS) binding. Treatment
with 10 lM edelfosine (Tocris) or 10 lMU73122 (Tocris) was done
1 h before DMR assays.
2.3. cAMP assay
Four thousand cells/well were incubated for 5 min with succi-
nate in buffer (Hank’s balanced salt solution (HBSS) (Invitrogen),
20 mM HEPES (pH 7.4) (Invitrogen), 0.1% bovine serum albumin
(BSA) (Sigma)) in small-volume 384-well plates (Greiner). cAMP
production was stimulated for 30 min with 10 lM forskolin (Sig-
ma), 1 mM IBMX (Sigma) and 250 lM Alexa Fluor 647-anti cAMP
antibody (PerkinElmer, LANCE cAMP kit). The reaction was stopped
with detection buffer containing 10 lM Biotin-cAMP and 15 lMLANCE Eu-W8044 labelled streptavidin (PerkinElmer, LANCE cAMP
kit). cAMP production was detected by homogeneous time re-
solved ﬂuorescence (HTRF) (kex = 340 nm, kem = 665 and 615 nm)
using a Pherastar (BMG Labtech). All reactions were performed at
room temperature.
2.4. IP1 assay
IP1 assays were conducted for 1 h at 37 C with 25,000 cells/
well (small-volume 384-well plates (Greiner)). IP1 production
was detected by HTRF as described above. All buffers and reagents
according to manufacturers protocol (Cisbio).
2.5. [35S]-GTPcS binding assays
Assays were performed at 30 C for 45 min in 200 ll of
50 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 25 mM HEPES (pH
7.4), 0.05 lg/ll of membrane protein, 0.01% BSA, 25 lM guano-
sine 50-diphosphate, 100 lM dithiothreitol and 0.53 nM
[35S]GTPcS (PerkinElmer). Non-speciﬁc binding was determined
in the presence of 20 lM GTPcS. The reaction was terminated
by addition of 50 mM Tris–HCl, 5 mM MgCl2, 50 mM NaCl (pH
7.4) and ﬁltration through 96-well GF/B ﬁlter plates (PerkinEl-
mer) using a Biomek FX (Beckman Coulter). Filters were dried
(30 min at 50 C), scintillation liquid (PerkinElmer) was added
and the bound radioactivity was determined using a scintillation
counter (Wallac). Peptide blocking of [35S]-GTPcS binding was
performed as described previously [21]. All chemicals from Sig-
ma unless stated otherwise.
2.6. Label-free assays – DMR
12,000 cells/well were cultured for 24 h in 384-well ﬁbronec-
tin-coated Epic biosensor plates (Corning). FBS was then removed
to increase expression of receptors, and cells were cultured for
an additional 24 h. Medium was exchanged for buffer (HBSS,
20 mM HEPES (pH 7.4) and 0.01% BSA) and cells were incubated
for 1 h inside the Epic Biosensor (Corning) at 26 C. A baseline
was read for 5 min; succinate was added using a CyBi-Well vario
(CyBio) and DMR was detected during 30 min. All buffer exchanges
were done with an ELx (Bio-Tek).
2.7. Fluorescent imaging plate reader (FLIPR) Ca2+-mobilization assays
10,000 cells/well were cultured in 384-well poly-D-Lysine
coated plates (Greiner) for 24 h. Cells were washed with 1 HBSS
and 20 mM HEPES (pH 7.4), loaded with Calcium 4 (Molecular De-
vices) and incubated for 1 h. The ﬂuorescence ((kex = 488 and
kem = 540 nm) was detected in a FLIPRTETRA (Molecular Devices) be-
fore and after addition of succinate. When studying succinate in-
duced Ca2+-mobilization in the absence and presence of 7 lM
forskolin the assay was performed with and without extracellular
Ca2+ by using HBSS without Ca2+/Mg2+ (Invitrogen). For all other
applications HBSS contained Ca2+/Mg2+.
2.8. Calculations and statistical analysis
Data were ﬁtted with a four parameter logistic ﬁt using the
equation y = A + ((B  A)/1 + ((C/x)^D))) where A is no activa-
tion, B is full activation, C is the EC50 and D is the Hill slope.
All data were based on at least three independent experiments.
Values shown are mean +/ S.E.M. Statistical signiﬁcance of
data for Ca2+-mobilization and G-protein C-terminal peptide
competition in GTPcS was determined with paired t-test anal-
ysis (P < 0.05).
Fig. 2. Succinate stimulated IP1 production in hGPR91-HEK293s cells untreated (d)
and PTX-treated (j). Data is shown as % effect, deﬁned as IP1 production
normalized to maximal effect of succinate.
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3.1. Succinate induced GPR91 signalling
To evaluate different downstream signalling events dependent
on GPR91 we examined the activity of succinate at human
GPR91 expressed in HEK293s cells, using a range of assay formats.
Succinate inhibited cAMP production measured using HTRF with
an EC50 of 50 ± 14 lM (n = 3) (Fig. 1). This inhibition was GPR91-
dependent since succinate was not able to reduce an equivalent
forskolin-mediated cAMP elevation in untransfected HEK293s cells
(data not shown). Using an HTRF IPone assay as a surrogate for IP3
production we found that formation of IP1 was mediated by succi-
nate with an EC50 of 421 ± 26 lM (n = 3) (Fig. 2). No formation of
IP1 could be detected in untransfected HEK293s cells with succi-
nate (data not shown). Succinate increased Ca2+-mobilization as
detected using a FLIPR with an EC50 of 45 ± 6 lM (n = 3) (data
not shown). Succinate did not cause an increase in Ca2+-mobiliza-
tion in untransfected HEK293s cells (data not shown).
3.2. Inhibition of Gai-protein coupling
To investigate the Gai-protein coupling we examined the effect
of PTX on the ability of GPR91 to inhibit cAMP formation. Pre-treat-
ment of hGPR91-HEK293s cells with PTX prevented succinate to
mediate an inhibition of cAMP, indicating a role for Gai (Fig. 1).
We evaluated the effect of PTX on succinate-induced IP1 formation
to determine the relationship between Gai and Gaq contribution to
succinate-dependent Ca2+-mobilization. Pre-treatment with PTX
also completely abolished the ability of GPR91 to mediate a succi-
nate-induced IP1 production (Fig. 2) demonstrating that this down-
stream signal is unlikely to be Gaq-dependent but instead
mediated by a PTX-sensitive mechanism. HEK293s cells expressing
the Gai coupled receptor RXFP3 and the mainly Gas coupled recep-
tor RXFP1 were used as PTX-sensitive and -resistant controls,
respectively (data not shown) and showed appropriate responses
as reported previously [22,23].
The direct increase in G-protein GTP-binding by GPR91 was de-
tected by [35S]-GTPcS-binding. Succinate increased GTPcS-binding
in membranes from hGPR91-HEK293s with an EC50 of 51 ± 6 lM
(n = 3). The response was GPR91 speciﬁc since succinate did not
mediate an increase in GTPcS-binding in membranes from
untransfected HEK293s cells (data not shown). Membranes pre-Fig. 1. Succinate inhibition of forskolin-stimulated cAMP production in untreated
(d) and PTX-treated (j) hGPR91-HEK293s cells. Data is shown as % inhibition of
forskolin-stimulated cAMP, normalized to maximal inhibition by succinate.
Fig. 3. Succinate mediated GTPcS-binding in membranes from untreated (d) and
PTX-treated (j) hGPR91-HEK293s cells. Data is shown as % effect, deﬁned as
speciﬁc GTPcS-binding normalized to maximal effect of succinate.pared from hGPR91-HEK293s cells pre-treated with PTX were
not able to mediate a succinate-stimulated GTPcS-binding
(Fig. 3). In addition we assessed the ability of G-protein C-terminal
peptides to compete the G-protein interaction of GPR91 in our
GTPcS assay. Whilst pre-treatment with a peptide equivalent to
the last twelve amino acids of Gai1/2 reduced the GTPcS signal an
equivalent peptide based on the C-terminus of Gaq did not (Fig. 4).
To further investigate other possible signalling pathways down-
stream of GPR91 we used a label-free technology (Corning Epic
biosensor) to look at the total cellular response. Succinate stimula-
tion of hGPR91-HEK293s cells showed a dose-dependent increase
in DMR with an EC50 of 124 ± 7 lM (n = 3). Succinate produced
no response in untransfected HEK293s cells (data not shown).
Treating the hGPR91-HEK293s cells with PTX completely removed
the ability for succinate to induce a DMR signal in these cells
(Fig. 5) conﬁrming that GPR91 signalling in HEK293s cells are so-
lely Gai-dependent.
Fig. 4. Mapping G-protein coupling of GPR91. Basal and 100 lM succinate
stimulated GTPcS-binding (% activity, mean ± S.E.M.) in hGPR91-HEK293s mem-
branes in the absence and presence of peptides equivalent to the C-termini of Gai1/2
and Gaq. Data were analysed using paired t-test (⁄⁄P < 0.05; n = 3).
Fig. 5. Succinate induced DMR response in untreated (d) and PTX-treated (j)
hGPR91-HEK293s cells. The DMR response is normalized to maximal succinate
response and shown as % effect.
Fig. 6. PLCb involvement in GPR91 signalling. Succinate mediated DMR response in
untreated (d), edelfosine-treated (N) and U73122-treated (j) hGPR91-HEK293s
cells. The DMR response is normalized to maximal succinate response and shown as
% effect.
Fig. 7. Dependence of extra cellular Ca2+ and co-dependence of Ca2+ and cAMP on
succinate mediated Ca2+-mobilization in hGPR91-HEK293s. Ca2+ was included or
excluded from the extra cellular buffer and 7 lM forskolin was included to
stimulate cAMP. No signiﬁcant (P > 0.2) inﬂuence of either forskolin stimulation or
removal of extracellular Ca2+ was seen on succinate mediated GPR91 effect on Ca2+-
mobilization. Effect is presented as effect over basal (basal = 100%). Basal effect is
shown in grey bars and succinate effect in blank bars.
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on Ca2+ release
To evaluate if PLCb was involved in the Ca2+-dependent pro-
cesses we used edelfosine and U73122 as inhibitors of PLCb and
studied their effect on the total GPR91-mediated cell response in
the DMR assay. Previous work in our lab has determined that the
optimal inhibitory concentration of both edelfosine and U73122
is 10 lM, which in this study blocked the succinate-induced re-
sponse completely, indicating that PLCb is involved in GPR91
downstream signalling (Fig. 6).
We examined the dependence on extracellular Ca2+ for GPR91-
mediated Ca2+ signalling by studying succinate-induced activation
in hGPR91-HEK293s cells both in presence and absence of extracel-
lular Ca2+ using FLIPR. The succinate induced Ca2+-mobilization
mediated by GPR91 was not affected by removal of extracellular
Ca2+ demonstrating that GPR91 is mediating Ca2+-mobilization
from intracellular stores (Fig 7). To determine if the cAMP inhibi-
tion activity and Ca2+-mobilization showed any co-dependence
we used 7 lM of forskolin to initiate increased cAMP production.However, we found that the succinate-dependent increase in
Ca2+-mobilization was unaltered (Fig. 7).
4. Discussion
It is a common physiological process that an extracellular stim-
ulus can activate multiple signalling pathways through coupling to
different G-proteins. This type of dual signalling may result from
receptors interacting with multiple G-proteins, i.e., activation of
the FFAR2 receptor leads to inhibition of adenylyl cyclase through
Gai and stimulation of PLC through Gaq [24]. However, this may
not be true in all cases; multiple signalling events may occur via
a single G-protein in response to stimulation by a given agonist.
For example, some investigators have found that several structur-
ally unrelated Gas coupled receptors shared the ability to stimulate
PLC in addition to stimulating adenylyl cyclase [25,26]. Previously
it has been reported that GPR91 signals through two G-protein
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abolished the succinate-induced cAMP inhibition and IP1 produc-
tion suggesting that GPR91 act exclusively through the Gai
pathway. This was also seen when a peptide equivalent to the C-
terminus of Gai1/2 reduced the GTPcS signal whilst a peptide based
on the C-terminus of Gaq did not. Whilst it is unlikely that Gaq
would contribute to the measured GTPcS signal, the lack of effect
of this peptide suggests that in this experimental system Gaq does
not bind to GPR91. Furthermore, in a DMR assay that works inde-
pendently of speciﬁc G-protein coupling and agonist trafﬁcking,
the succinate response at GPR91 expressed in HEK293s cells was
entirely PTX-sensitive. These results demonstrate that GPR91 in
our expression system acts through Gai not only to inhibit cAMP
production but also to induce Ca2+-mobilization.
Receptor-induced activation of a G-protein is accomplished by
the dissociation of its a subunit from the bc dimer, both of which
may in turn modulate target effectors. Evidence has been gener-
ated showing that the free bc dimers play an important role in sig-
nal transduction processes [27]. Furthermore, it is widely accepted
that Gbc is the signal transducer for the PTX-sensitive PLC stimu-
lation found for many Gai coupled receptors [28] as well as being
the mediator for stimulation of the extracellular-signal-regulated
kinase (ERK) mitogen-activated protein kinase (MAPK) pathway
[29]. The extensively characterized adrenergic a2A receptor has
been shown to give a Ca2+-mobilization in a PTX-sensitive manner
with involvement of both PLCb and Gbc subunits [30]. Activation
of ERK1/2 and Akt mediated by the a2A receptor is also suggested
to proceed through the Gbc subunits [31–33]. Puriﬁed PTX-sensi-
tive Gai family subunits are unable to reconstitute activation of
PLC. On the other hand puriﬁed Gbc subunits are able to activate
PLCb isoforms in vitro, albeit at relatively high concentrations com-
pared to typical activation by Gaq subunits [28,34,35]. Many of the
GPCR-dependent physiological processes inhibited by PTX are
mediated by Gbc rather than Ga [36–39]. Thus, most Gbc depen-
dent signalling appears to arise from Gai proteins.
It is recognized in many cellular systems that the receptor/G-
protein activation of PLC and IP3 production is the transduction
pathway regulating the release of Ca2+ from internal stores [40].
The amino steroid compound U73122 and edelfosine (ET-18-
OCH3) are reported to act as speciﬁc inhibitors of PLC and they
have become important tools in establishing the link between
PLC activation and cellular Ca2+-mobilization [41,42]. We have
shown that the succinate-induced GPR91 signalling detected by
DMR is sensitive to both edelfosine and U73122, establishing that
PLCb is involved in GPR91 signalling. This is consistent with PLC
activation being mediated through bc subunits derived from
PTX-sensitive Gai proteins as opposed to classical Gaq stimulated
Ca2+-mobilization.
It has previous been shown that PLCd activation by Gai/o-cou-
pled receptor agonists are mediated by Ca2+ inﬂux via store oper-
ated Ca2+ channels, by showing that agonist responses are not
observed in the absence of extracellular Ca2+ [43]. The methacoline
induced Ca2+-mobilization by the Gai coupled M2 receptor was on
the other hand not reduced upon removal of extracellular Ca2+
[44]. To investigate if succinate-induced Ca2+-mobilization for
GPR91 was dependent on extracellular calcium we studied Ca2+-
mobilization upon succinate activation in the absence of extracel-
lular Ca2+. Activation of GPR91 was not impacted by removal of
extracellular Ca2+ indicating that membrane Ca2+ channels are
not involved in the signalling through Gbc and PLCb. This implies
that GPR91 is mediating Ca2+-mobilization from intracellular
stores, this has also been seen for other Gai/o receptors [30]. Our
data suggests that there is no co-dependence on Ca2+-mobilization
and cAMP since stimulation of adenylate cyclase with forskolin did
not alter the succinate-induced Ca2+-mobilization.In earlier studies recombinant GPR91 has been shown to acti-
vate both Gai and Gaq pathways through which Gai inhibits
cAMP production and Gaq activates Ca2+-mobilization [9,45].
These conﬂicting results may be due to the different cell systems
or promiscuous G-protein coupling. However, results similar to
ours have been reported in the erythroleukemic cell line TF-1
with endogenous expressed GPR91 [20]. Here the Gai pathway
was shown to mediate succinate-induced activation of ERK1/2
and inositol phosphate accumulation. Succinate has been shown
to regulate lipolysis in white adipose tissue in a PTX-sensitive
manner [16]. Succinate also induced platelet aggregation and
inhibited cAMP production in platelets, but did not have any ef-
fect on Ca2+-mobilization in this cell type [46]. The author’s
hypothesis for this is the lack of Gbcmediated activation of
PLCb in platelets. In primary hepatic stellate cells succinate did
accelerate stellate cell activation but did not inhibit cAMP pro-
duction or increased cytocolic Ca2+ [47]. There are evidence for
differences in de-sensitization and internalization of GPR91 in
different cell types. In HEK293s cells recombinant GPR91 was
shown to internalize upon stimulation with succinate [9]
whereas in polarized renal Madin-Darby Canine Kidney (MDCK)
cells succinate did not induce internalization of recombinant
GPR91 but instead a temporal desensitization of the receptor
[45]. The GPR91 signalling seems to be highly speciﬁc depending
on cell type and this may give some answer to the heterogeneity
in signalling pathways that have been observed also in recombi-
nant systems. This study demonstrates that GPR91 activates Gi
and PLCb signalling, which we believe is mediated by the bc
complex. It is clear that GPR91 can induce different signalling
in different cell types not only by recruiting different Ga subunits
but also through the bc complex. This work clearly demonstrates
the importance of investigating not only the second messengers
(i.e., Ca2+ or inositol phosphate) but also the actual G-proteins in-
volved in the signalling. A switch in G-protein coupling is not
limited to engineered cells but can also occur with native recep-
tor expression in host cells. Endogenous dopamine D1/D2 recep-
tor responses couples to different G-proteins in different cell
types further highlighting the importance to determine the G-
protein coupling in each cell type [48]. In conclusion, when ana-
lyzing the signalling properties of agonists at GPR91 caution is
required to ensure that the cellular system used has the expected
signalling capability.
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